Cogenics provides a full range of genomics services for both research and regulated projects, including services to support pharmacogenomics discovery and validation and biomarker research and development. The Cogenics division offers integrated services for DNA and RNA extraction, genotyping, full sequencing services including next generation genomic sequencing, and gene expression. The Company is headquartered in Newton, Massachusetts with operations in Texas, and North Carolina as well as internationally in the UK, France, and Germany.